557 related articles for article (PubMed ID: 17095756)
1. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
Shah YM; Morimura K; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
[TBL] [Abstract][Full Text] [Related]
3. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
[TBL] [Abstract][Full Text] [Related]
4. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
5. Role of metallothionein in murine experimental colitis.
Tsuji T; Naito Y; Takagi T; Kugai M; Yoriki H; Horie R; Fukui A; Mizushima K; Hirai Y; Katada K; Kamada K; Uchiyama K; Handa O; Konishi H; Yagi N; Ichikawa H; Yanagisawa R; Suzuki JS; Takano H; Satoh M; Yoshikawa T
Int J Mol Med; 2013 May; 31(5):1037-46. PubMed ID: 23467591
[TBL] [Abstract][Full Text] [Related]
6. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
[TBL] [Abstract][Full Text] [Related]
7. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.
Shah YM; Ma X; Morimura K; Kim I; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1114-22. PubMed ID: 17170021
[TBL] [Abstract][Full Text] [Related]
8. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor gamma agonist alleviates the symptoms of DSS-induced colitis.
Yamamoto K; Ninomiya Y; Iseki M; Nakachi Y; Kanesaki-Yatsuka Y; Yamanoue Y; Itoh T; Nishii Y; Petrovsky N; Okazaki Y
Biochem Biophys Res Commun; 2008 Mar; 367(3):566-72. PubMed ID: 18191038
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade.
Takagi T; Naito Y; Tomatsuri N; Handa O; Ichikawa H; Yoshida N; Yoshikawa T
Redox Rep; 2002; 7(5):283-9. PubMed ID: 12688511
[TBL] [Abstract][Full Text] [Related]
10. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis.
Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K
Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease.
Hontecillas R; Horne WT; Climent M; Guri AJ; Evans C; Zhang Y; Sobral BW; Bassaganya-Riera J
Mucosal Immunol; 2011 May; 4(3):304-13. PubMed ID: 21068720
[TBL] [Abstract][Full Text] [Related]
13. Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis.
Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Brzozowski T; Slomka M
J Physiol Pharmacol; 2013 Oct; 64(5):587-95. PubMed ID: 24304573
[TBL] [Abstract][Full Text] [Related]
14. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.
Naito Y; Takagi T; Handa O; Ishikawa T; Nakagawa S; Yamaguchi T; Yoshida N; Minami M; Kita M; Imanishi J; Yoshikawa T
J Gastroenterol Hepatol; 2003 May; 18(5):560-9. PubMed ID: 12702049
[TBL] [Abstract][Full Text] [Related]
15. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
17. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
[TBL] [Abstract][Full Text] [Related]
18. A soybean and fish oil mixture with different n-6/n-3 PUFA ratios modulates the inflammatory reaction in mice with dextran sulfate sodium-induced acute colitis.
Huang CH; Hou YC; Yeh CL; Yeh SL
Clin Nutr; 2015 Oct; 34(5):1018-24. PubMed ID: 25434577
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental colitis by intestinal mononuclear phagocytes.
Qualls JE; Kaplan AM; van Rooijen N; Cohen DA
J Leukoc Biol; 2006 Oct; 80(4):802-15. PubMed ID: 16888083
[TBL] [Abstract][Full Text] [Related]
20. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T; Kotake Y
Antioxid Redox Signal; 2002 Feb; 4(1):195-206. PubMed ID: 11970853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
